Camelia Chifu

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Medicine, Oncology, Surgery +13

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

Corrado Tinterri, Damiano Gentile, Wolfgang Gatzemeier et al. · Annals of Surgical Oncology · 2022 · 154 citations · Full text

Medicine, Oncology, Surgery +17

Sentinel lymph node biopsy <i>versus</i> axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment

Corrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier et al. · British journal of surgery · 2023 · 57 citations · Full text

Medicine, Oncology, Surgery +17

Sentinel Node Biopsy in Patients with Previous Breast Aesthetic Surgery

J.R. García-Talavera Fernández, Stefano Martella, Giuseppe Trifirò et al. · Annals of Surgical Oncology · 2009 · 49 citations

Medicine, Oncology, Surgery +14